Drug intelligence / Profile preview

fructosin

Development stage
Unknown
Lead developer
STADA
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Fructosin is an oral capsule product containing the enzyme **xylose isomerase**. It is designed for the prevention and alleviation of symptoms related to **fructose malabsorption**, such as abdominal pain, nausea, and disturbed intestinal function. The mechanism relies on the conversion of fructose (fruit sugar), which is poorly absorbed in some individuals, into glucose, which is more readily absorbed in the small intestine. This reduces the amount of unabsorbed fructose that reaches the colon, thereby diminishing symptoms caused by its bacterial breakdown. Fructosin is not suitable for individuals with hereditary fructose intolerance. It does not contain histamine, lactose, or gluten, and lacks preservatives or artificial flavorings. It is classified as a medical device rather than a pharmaceutical.

Brand names
FRUCTOSiN
Other names
fructosin
02

Targets

COM crystal surface (Calcium oxalate monohydrate crystal surface)MG (Mycoplasma gallisepticum)

Beyond the preview

Go deeper on fructosin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fructosin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call